Objective of BINASP is to build-up a system of bio-nanotechnology research infrastructures and facilities in AREA Science Park (Trieste-Region Friuli Venezia Giulia-Italy), within the context of the socalled “TDMB-Technology District of Molecular Biomedicine” set up in the Region Friuli Venezia Giulia at the end of 2004.

AREA Science Park is one of the leading European science & technology parks and is managed by the Consorzio per l’AREA di Ricerca Scientifica e Tecnologica di Trieste (hereinafter referred as Consorzio AREA), a national research institution which is under the authority of the Italian Ministry of Education, University and Reasearch.

The TDMB is an innovative cognitive district, an excellence structure officially endorsed by the above mentioned Italian Ministry, where development programmes driven by research and industry stakeholders are strongly supported by public and private funds.

The core and main driver of the TDMB is the “CBM-Centre for Biomolecular Medicine”, a syndicated company leaded by the Consorzio AREA which presently involves 15 shareholders, including research institutions, hi-tech manufacturing companies and financial institutes.

BINASP’s infrastructures will consist of nr.7 newly established bio-nanotech related laboratories which are included in a more extended networked system of excellence research structures which are mainly concentrated in the AREA Science Park premises.

BINASP’s s goal will be achieved starting from the assets of the CBM and from the renowned European milieu of AREA Science Park. Cornerstones of BINASP: 

• to promote innovative research in nanotechnology applied to biology and medicine, and develop advanced instrumentation;
• to develop collaborations with EU nanotech R&D Centers, through the organization of scientific meetings, joint research, projects, exchange programs; 
• to develop high education programmes by the promotion of PhD, start-up grants and fellowships;
• to manage advanced instrumentation and laboratories for common research use, provide consultancy to fund raising and management for partners and others institutions;
• to set-up products, provide services and instruments useful to diagnostic and therapeutic purposes;
• to exploit the market value of the relevant research results.

Initial funding and locations of the project will be provided by the BINASP Partners as well as other public-private institutions; the project sustainability will be subsequently affirmed by the same institutions as well as by grants and market revenues of the intellectual property.

BINASP perfectly fulfils the goals of the FP6, since it provides the basis of a European crosscutting hi-tech platform development starting from the existing bulk of sectorial excellence competence centres.